ICU Medical Financials
ICUI Stock | USD 159.75 2.00 1.27% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.81 | 0.7671 |
|
| |||||
Current Ratio | 2.41 | 2.5346 |
|
|
The financial analysis of ICU Medical is a critical element in measuring its lifeblood. Investors should not minimize ICU Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
ICU | Select Account or Indicator |
Understanding current and past ICU Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ICU Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in ICU Medical's assets may result in an increase in income on the income statement.
ICU Medical Earnings Geography
ICU Medical Stock Summary
ICU Medical competes with Femasys, GlucoTrack, Disney, Walmart, and Johnson Johnson. ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California. I C operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 15300 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US44930G1076 |
CUSIP | 44930G107 |
Location | California; U.S.A |
Business Address | 951 Calle Amanecer, |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.icumed.com |
Phone | 949 366 2183 |
Currency | USD - US Dollar |
ICU Medical Key Financial Ratios
Return On Equity | -0.0535 | ||||
Profit Margin | (0.05) % | ||||
Operating Margin | 0.04 % | ||||
Price To Sales | 1.65 X | ||||
Revenue | 2.26 B |
ICU Medical Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.7B | 1.8B | 1.9B | 4.5B | 4.4B | 4.6B | |
Other Current Liab | 105.8M | 109.0M | 96.5M | 192.9M | 213.7M | 224.4M | |
Net Debt | (232.4M) | (344.0M) | (507.8M) | 1.4B | 1.5B | 1.5B | |
Retained Earnings | 721.8M | 808.7M | 911.8M | 837.5M | 807.8M | 848.2M | |
Accounts Payable | 128.6M | 71.9M | 81.1M | 215.9M | 150.0M | 157.5M | |
Cash | 268.7M | 396.1M | 552.8M | 208.8M | 254.2M | 137.4M | |
Net Receivables | 202.2M | 124.1M | 105.9M | 221.7M | 182.1M | 191.3M | |
Inventory | 337.6M | 314.9M | 290.2M | 696.0M | 709.4M | 744.8M | |
Total Liab | 315.1M | 261.4M | 264.7M | 2.4B | 2.3B | 2.4B | |
Total Current Assets | 882.2M | 920.8M | 1.0B | 1.2B | 1.2B | 1.3B | |
Other Current Assets | 4.4M | 85.5M | 71.3M | 101.6M | 75.0M | 78.8M | |
Intangible Assets | 211.4M | 197.2M | 188.3M | 982.8M | 870.6M | 914.1M | |
Common Stock | 2.1M | 2.1M | 2.1M | 2.4M | 2.4M | 1.8M | |
Other Assets | 77.0M | 146.1M | 106.3M | 104.4M | 120.1M | 126.1M | |
Treasury Stock | (95K) | (157K) | (39K) | (27K) | (31.1K) | (32.6K) | |
Other Liab | 37.8M | 18.1M | 22.1M | 244.7M | 281.4M | 295.5M | |
Net Tangible Assets | 1.2B | 1.3B | 1.6B | (342.1M) | (393.4M) | (373.7M) | |
Good Will | 31.2M | 33.0M | 43.4M | 1.4B | 1.5B | 1.5B | |
Capital Surpluse | 657.9M | 668.9M | 693.1M | 721.4M | 829.6M | 871.1M |
ICU Medical Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 549K | 1.8M | 858K | 66.4M | 102.7M | 107.9M | |
Total Revenue | 1.3B | 1.3B | 1.3B | 2.3B | 2.3B | 2.4B | |
Gross Profit | 471.9M | 461.5M | 491.5M | 697.8M | 739.9M | 776.9M | |
Operating Income | 63.2M | 41.8M | 52.4M | (8.7M) | 22.8M | 30.6M | |
Ebit | 63.2M | 99.2M | 124.2M | (67.3M) | 57.0M | 37.6M | |
Ebitda | 148.4M | 194.1M | 223.5M | 191.5M | 307.7M | 323.1M | |
Cost Of Revenue | 794.3M | 809.5M | 824.8M | 1.6B | 1.5B | 1.6B | |
Income Before Tax | 114.7M | 97.5M | 123.2M | (114.4M) | (78.3M) | (74.4M) | |
Net Income | 101.0M | 86.9M | 103.1M | (74.3M) | (29.7M) | (28.2M) | |
Income Tax Expense | 13.7M | 10.6M | 20.1M | (40.1M) | (48.6M) | (46.2M) | |
Research Development | 48.6M | 42.9M | 47.5M | 93.0M | 85.3M | 89.6M | |
Tax Provision | 13.7M | 10.6M | 20.1M | (40.1M) | (48.6M) | (46.2M) | |
Net Interest Income | (549K) | (1.8M) | (858K) | (66.4M) | (95.2M) | (90.5M) | |
Interest Income | 6.3M | 1.9M | 2.8M | 4.4M | 7.5M | 4.2M |
ICU Medical Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (25.0M) | 19.2M | 20.8M | (201.1M) | (6.1M) | (5.8M) | |
Change In Cash | (76.1M) | 127.4M | 156.7M | (344.0M) | 45.4M | 47.7M | |
Free Cash Flow | (4.1M) | 122.4M | 186.4M | (161.5M) | 72.5M | 76.2M | |
Depreciation | 85.2M | 94.8M | 89.7M | 235.2M | 228.8M | 240.2M | |
Other Non Cash Items | (22.2M) | 30.3M | 29.5M | 44.7M | 62.1M | 65.2M | |
Capital Expenditures | 106.0M | 100.4M | 81.2M | 99.3M | 93.7M | 98.4M | |
Net Income | 101.0M | 86.9M | 103.1M | (74.3M) | (29.7M) | (28.2M) | |
End Period Cash Flow | 268.7M | 396.1M | 552.8M | 208.8M | 254.2M | 137.4M | |
Investments | 15.3M | (3.9M) | 4.7M | (1.9B) | (87.9M) | (92.3M) | |
Change Receivables | 20.7M | (23.7M) | 78.0M | 13.8M | 15.8M | 16.6M | |
Change To Netincome | 2.6M | 46.3M | 36.1M | 73.8M | 84.8M | 89.1M |
ICU Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ICU Medical's current stock value. Our valuation model uses many indicators to compare ICU Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ICU Medical competition to find correlations between indicators driving ICU Medical's intrinsic value. More Info.ICU Medical is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . As of now, ICU Medical's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ICU Medical's earnings, one of the primary drivers of an investment's value.ICU Medical's Earnings Breakdown by Geography
ICU Medical Systematic Risk
ICU Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ICU Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on ICU Medical correlated with the market. If Beta is less than 0 ICU Medical generally moves in the opposite direction as compared to the market. If ICU Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ICU Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ICU Medical is generally in the same direction as the market. If Beta > 1 ICU Medical moves generally in the same direction as, but more than the movement of the benchmark.
ICU Medical Thematic Clasifications
ICU Medical is part of several thematic ideas from Office Supplies to Baby Boomer Prospects. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasToday, most investors in ICU Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ICU Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ICU Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
ICU Medical November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ICU Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ICU Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of ICU Medical based on widely used predictive technical indicators. In general, we focus on analyzing ICU Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ICU Medical's daily price indicators and compare them against related drivers.
Information Ratio | (0.1) | |||
Maximum Drawdown | 7.25 | |||
Value At Risk | (2.50) | |||
Potential Upside | 2.77 |
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |